Back to Results
First PageMeta Content
Chemistry / National Health Service / Statins / Merck / Quality and Outcomes Framework / Simvastatin / Myocardial infarction / Stroke / Cardiovascular disease / Health / Aging-associated diseases / Medicine


Document Date: 2014-04-04 06:29:31

Open Document

File Size: 82,58 KB

Share Result on Facebook

Country

United Kingdom / Northern Ireland / Scotland / Wales / /

Currency

GBP / /

IndustryTerm

validated assessment tool / agreed risk assessment tool / NICE technology appraisal guidance / prevention of cardiovascular disease / /

MedicalCondition

fatal and non-fatal myocardial infarction / hypertension / nonfatal stroke / CHD / disease / cardiovascular diseases / stroke / diabetes / Cardiovascular disease / /

MedicalTreatment

statin therapy / /

Organization

NHS / NHS Information Centre / /

Position

representative / /

Product

simvastatin / /

ProvinceOrState

Michigan / /

Technology

CVD / /

URL

www.nice.org.uk/guidance/TA94 / www.qof.ic.nhs.uk / www.nice.org.uk/guidance/CG67 / /

SocialTag